Please assess the completion status of the following clinical trial:

Trial Title: Quetiapine Fumarate Bipolar Maintenance Monotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Signed informed consent~* 18 years or older~* A diagnosis of Bipolar I Disorder~* Have a current manic, depressed or mixed episode~* Have had a manic, depressed or mixed episode during the last 26 weeks that was treated with quetiapine~* Female patients of childbearing potential must be using a reliable method of contraception~Exclusion Criteria:~* Pregnancy~* Substance or alcohol dependence at enrollment~* Unstable thyroid function~* Unstable Diabetes~* Unstable or inadequately treated medical illness e.g., angina pectoris and hypertension~* Use of an experimental drug within 30 days of enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).